Integrated BioPharma, Inc.
General ticker "INBP" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $8.5M (TTM average)
Integrated BioPharma, Inc. follows the US Stock Market performance with the rate: 28.6%.
Estimated limits based on current volatility of 8.3%: low 0.29$, high 0.34$
Factors to consider:
- US accounted for 84.2% of revenue in the fiscal year ended 2024-06-30
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-06-30 to 2025-06-29
- 2023-06-30 to 2024-06-29 estimated range: [0.21$, 0.44$]
- 2024-06-29 to 2025-06-29 estimated range: [0.24$, 0.48$]
Financial Metrics affecting the INBP estimates:
- Negative: Non-GAAP EPS, $ of 0.03 <= 0.04
- Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of -0.13
- Positive: Inventory ratio change, % of -2.80 <= -1.01
- Positive: -0.07 < Operating profit margin, % of 0.24
- Negative: Industry earnings per price (median), % of -0.98 <= 0
- Positive: Interest expense per share, $ of 0 <= 0.10
- Negative: Industry operating cash flow per share per price (median), % of -1.48 <= 2.82
Short-term INBP quotes
Long-term INBP plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $56.25MM | $50.67MM | $50.32MM |
| Operating Expenses | $53.50MM | $50.55MM | $50.07MM |
| Operating Income | $2.75MM | $0.12MM | $0.25MM |
| Non-Operating Income | $-0.15MM | $-0.02MM | $0.02MM |
| Interest Expense | $0.13MM | $0.01MM | $0.02MM |
| Income(Loss) | $2.60MM | $0.10MM | $0.27MM |
| Taxes | $-1.24MM | $0.13MM | $0.16MM |
| Profit(Loss)* | $3.84MM | $-0.03MM | $0.11MM |
| Stockholders Equity | $18.57MM | $18.86MM | $19.24MM |
| Inventory | $11.05MM | $10.26MM | $11.24MM |
| Assets | $25.25MM | $25.43MM | $26.21MM |
| Operating Cash Flow | $4.09MM | $1.23MM | $0.94MM |
| Capital expenditure | $0.49MM | $0.12MM | $0.55MM |
| Investing Cash Flow | $-0.47MM | $-0.11MM | $-0.55MM |
| Financing Cash Flow | $-3.50MM | $-0.14MM | $-0.03MM |
| Earnings Per Share** | $0.13 | $-0.00 | $0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.